Regeneron and Sanofi’s Praluent gets European approval for reducing cardiovascular risk in atherosclerotic disease patients

pharmanewsdaily- March 24, 2019 0

Regeneron Pharmaceuticals and Sanofi have received a significant boost with the European Commission's (EC) approval of Praluent (alirocumab) for a new indication. The approval enables ... Read More

An egg a day might reduce risk of heart disease: Study

pharmanewsdaily- January 28, 2019 0

New Delhi, Jan 28 (ANI): A new study conducted in China finds that eating an egg a day may lower risk of cardiovascular disease. The ... Read More

FDA approves Novo Nordisk’s Victoza for heart disease treatment in type 2 diabetes patients

pharmanewsdaily- August 26, 2017 0

In a significant advancement for diabetes care, Danish pharmaceutical giant Novo Nordisk has received approval from the U.S. Food and Drug Administration (FDA) to use ... Read More

What meant is by Tachycardia?

pharmanewsdaily- September 17, 2013 0

Tachycardia: Tachycardia is a medical term for the conditions like rapid heart beat, fluttering heart or pounding of heart. Causes for Tachycardia: Sinus tachycardia (Photo ... Read More

12324 / 24 Posts